About Us

Local Sites

Businesses

People

ESG & Impact

Newsroom

Bain Capital, LP is one of the world’s leading private investment firms with approximately $185 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact ir@baincapital.com.

Sign on to your account

Questions?
Call Us: 24 x 7 Global Phone Support
Email Us: support@intralinks.com
Meet the Bain Capital Investor Relations team
Adam M. Koppel, MD, PhD

Adam M. Koppel, MD, PhD

Partner
Life Sciences
Boston

Experience

Dr. Adam M. Koppel initially joined Bain Capital in 2003 and rejoined the firm in 2016. He is a Partner on the Life Sciences team. Previously, Adam was a member of the Public Equity team where he worked as a leader within the healthcare sector.

, In between his time at Bain Capital, Adam was EVP of Corporate Development and Chief Strategy Officer at Biogen. Prior to initially joining Bain Capital, he was an Associate Principal at McKinsey & Co in New Jersey where he served a variety of healthcare companies.


Education

Adam received an MD and PhD in neuroscience from the University of Pennsylvania School of Medicine. He also received an MBA from The Wharton School at the University of Pennsylvania, where he was a Palmer Scholar. He graduated magna cum laude from Harvard University with an AB and AM in history and science.